Ignite Creation Date:
2024-05-05 @ 5:07 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00397956
Status:
COMPLETED
Last Update Posted:
2015-10-30
First Post:
2006-11-09
Brief Title:
To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections 0826-053
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
An Open-Label Single-Arm Non-Comparative Study to Evaluate the Efficacy Tolerability Convenience of InvanzTM Ertapenem Sodium In the Treatment of Community-Acquired Sepsis in Adults
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To collect clinical response data with the use of ertapenem in community acquired sepsis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006_047 | None | None | None |